LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1,732 Cr | ₹-2,184 Cr | ₹-337 Cr | ₹-1,572 Cr | ₹-1,885 Cr |
What is the latest Cash Flow from Financing Activities ratio of LUPIN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1,732 Cr |
| Mar2024 | ₹-2,184 Cr |
| Mar2023 | ₹-337 Cr |
| Mar2022 | ₹-1,572 Cr |
| Mar2021 | ₹-1,885 Cr |
How is Cash Flow from Financing Activities of LUPIN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,732 Cr | Positive | |
| Mar2024 | ₹-2,184 Cr | Negative | |
| Mar2023 | ₹-337 Cr | Negative | |
| Mar2022 | ₹-1,572 Cr | Negative | |
| Mar2021 | ₹-1,885 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹113,835.9 Cr | 3.9% | 9.8% | 28.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 3.9% |
9.8% |
28.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses